Chief Pharmacist Update - 20 September 2024
Australia is currently experiencing a shortage of all brands of Tenofovir disoproxil and Emtricitabine (300/200) commonly used for HIV Pre Exposure Prophylaxis or ‘PrEP’.
Australia is currently experiencing a shortage of all brands of Tenofovir disoproxil and Emtricitabine (300/200) commonly used for HIV Pre Exposure Prophylaxis or ‘PrEP’.